{"document": {"publication": "Tag My News", "full_text": "a clinical trial of amgen inc's bone drug, xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain -- a finding the company believes will help boost the drug's market potential.", "title": "amgen's xgeva delays prostate cancer bone pain", "line_count": 1, "filename": "11619", "publication_date": "17-05-2011 16:43:41", "lines_and_colors": [["a clinical trial of amgen inc's bone drug, xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain -- a finding the company believes will help boost the drug's market potential.", {}]]}}